Harry Stylli has been appointed the new President and CEO of Sequenom, the company said this week. Stylli most recently served as President and CEO of Xencor, where he is still a member of the board of directors. He earned a PhD from the London University's Faculty of Medicine, and an MA in business administration from the UK's Open University.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.